Dr. Sharad Khurana, MD, MS

Dr. Khurana practices at University of Arizona in Tucson, Arizona.

Dr. Khurana's NPI, 1659788529, was assigned on July 12, 2014. Dr. Khurana holds Arizona license 61062.

Dr. Khurana's primary practice is University of Arizona, at 1501 N Campbell Ave, Tucson, AZ 85724 in Pima County. The practice phone is (520) 626-2761.

Dr. Khurana's primary practice is University of Arizona in Tucson, Arizona. Dr. Khurana is also affiliated with Banner - University Medical Center Tucson. The medical group on file is Banner Medical Group. Dmand AI also links Dr. Khurana to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khurana practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Khurana's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khurana is licensed in Arizona.

CMS data shows 443 Medicare services from Dr. Khurana across 7 procedure codes in 2024, for 155 Medicare patients. Medicare paid $36,070 for them.

CMS counts 155 Medicare patients who saw Dr. Khurana in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khurana's median patient age at 67, with 49% women.

In 2024, Dr. Khurana wrote 1,045 Medicare Part D claims for 101 patients. 79% of them were for generic drugs. CMS names the drug for 822 of them, across 26 drugs with 11 or more claims each, at $1,589,876 in total drug cost. In 2023, CMS named 615 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Khurana for performance year 2024, reported through an alternative payment model (APM). Dr. Khurana accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 18 papers to Dr. Khurana, published from 2015 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Hematopoietic Stem Cell Transplantation, Bendamustine Hydrochloride and Cyclophosphamide. Dr. Khurana has published most often in Case Rep Hematol. Dr. Khurana's most frequent co-authors are Liuyan Jiang, MD, James M. Foran, MD and Sunil H. Abhyankar, MD.

Dmand AI links Dr. Khurana to 1 clinical trial. Conditions studied include Myelodysplastic Syndromes and Bone Marrow Diseases.

CMS Open Payments shows 39 general payments to Dr. Khurana from 20 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 30% of the total. Syndax Pharmaceuticals, Inc. paid the most, $5,885.